Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples